Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry.

Konrad van der Zwet Marloes de KovelJayashree MotwaniChris van GeetBeatrice NolanHeidi GlosliCarmen Escuriola EttingshausenChristoph KönigsTami Livnat Kathelijn Fischernull null

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

This study showed improved bleeding control compared to previous treatment and a favourable safety profile during emicizumab therapy in paediatric haemophilia A patients.

Keyphrases

end stage renal disease
atrial fibrillation
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
young adults
intensive care unit
prognostic factors
mesenchymal stem cells
bone marrow
replacement therapy